Feedback
Settings

Settings

Goto Application

1. WO2004019865 - AMELIORATION OF EFFECTS OF CIGARETTE SMOKE

PermaLink
Publication Number WO/2004/019865
Publication Date 11.03.2004
International Application No. PCT/US2003/026250
International Filing Date 22.08.2003
IPC
A61K 38/04 2006.01
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
38Medicinal preparations containing peptides
04Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
CPC
A61K 38/046
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
38Medicinal preparations containing peptides
04Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
046Tachykinins, e.g. eledoisins, substance P; Related peptides
A61K 9/0073
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
9Medicinal preparations characterised by special physical form
0012Galenical forms characterised by the site of application
007Pulmonary tract; Aromatherapy
0073Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy;
A61K 9/0075
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
9Medicinal preparations characterised by special physical form
0012Galenical forms characterised by the site of application
007Pulmonary tract; Aromatherapy
0073Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy;
0075for inhalation via a dry powder inhaler [DPI], e.g. comprising micronized drug mixed with lactose carrier particles
A61K 9/0078
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
9Medicinal preparations characterised by special physical form
0012Galenical forms characterised by the site of application
007Pulmonary tract; Aromatherapy
0073Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy;
0078for inhalation via a nebulizer such as a jet nebulizer, ultrasonic nebulizer, e.g. in the form of aqueous drug solutions or dispersions
A61P 11/00
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
11Drugs for disorders of the respiratory system
A61P 11/08
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
11Drugs for disorders of the respiratory system
08Bronchodilators
Applicants
  • WITTEN, Mark, L. [US]/[US]
  • HARRIS, David, T. [US]/[US]
Inventors
  • WITTEN, Mark, L.
  • HARRIS, David, T.
Agents
  • KAGAN, Sarah, A.
Priority Data
60/406,03627.08.2002US
Publication Language English (EN)
Filing Language English (EN)
Designated States
Title
(EN) AMELIORATION OF EFFECTS OF CIGARETTE SMOKE
(FR) AMELIORATION DES EFFETS DE LA FUMEE DE CIGARETTE
front page image
Abstract
(EN)
Aerosolized Substance P can be used to mitigate the effects of main-stream or side-stream cigarette smoke. Functional, structural, genetic, organ limited, and systemic effects of the smoke are mitigated by the Substance P treatment.
(FR)
Une substance sous forme d'aérosol P peut être utilisée pour limiter les effets de la fumée principale ou de la fumée indirecte des cigarettes. Les effets fonctionnels, structurels, génétiques, limités aux organes et systémiques de la fumée sont limités par le traitement avec la substance P.
Also published as
EP1536816
CN1678337
CA2496447
AU2003262773
US20070207123
JP2005537322
VN1200500215
VN11316
Latest bibliographic data on file with the International Bureau
# -